In April, FDA Commissioner Dr. Robert Califf laid out areas of challenge and opportunity when it comes to improving health outcomes, restoring public trust in science, and making the most of our ongoing investments in data analytics and clinical research. More specifically, Califf made clear that our current healthcare system is “very well aligned to improve outcomes for some people and not others.”
Califf went on to note that we need better mechanisms for evidence generation and actionable decision-making if we are to improve health equity and bring better outcomes to traditionally underserved populations. His vision for doing so builds upon the FDA’s existing partnerships with healthcare providers, life sciences companies, patient advocates, and others.
